Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy
1 hour ago · The Hindu
Global India
& newspaper;
Read Full Article →
Sourced From
The Hindu
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
Source: The Hindu — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: The Hindu — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.